Profile Category: Advisors

Home / Advisors
Markus Van Kempen
Profiles

Markus Van Kempen

Markus is a Venture Capitalist within IBM Corporate Strategy at CHQ. He is responsible for working across IBM to design, develop and support PoC proposals with IBM teams and customers. Markus specializes in the Internet of Things projects and also brings 15+ years of consulting and implementation experience in SAP and Mobile on global projects, as well as skills as a software engineer. He has a keen interest in debating and predicting The Next Big Thing in technology. 

Dinaro Ly
Profiles

Dinaro Ly

Dinaro has 10+ years of experience in marketing, business development and partnerships spanning across B2B and B2C segments in the retail, financial services, and startup space. He was director of market development and partnerships for digital payments at MasterCard Canada, where he was responsible for driving digital adoption and strategic alliances with large-scale retailers, FI’s and payment service providers. Prior to MasterCard, Dinaro led business development and partnerships at RedFlagDeals.com, a loyalty and deal content venture (acquired by The Yellow Pages Group). Prior to RedFlagDeals, he had broad oversight and accountability for Dell Canada’s, SMB digital marketing portfolio.

He currently sits on the board of ACT Canada and Blockchain Canada on behalf of MaRS to continue to build relationships with financial institutions and the venture community with the goal of supporting programs related to innovation, payments, commerce, cryptocurrencies and Blockchain.

Dr. Thomas Sull
Profiles

Dr. Thomas Sull

Dr. Thomas Sull is an emergency room physician currently practicing at Mackenzie Health in Richmond Hill, Ontario. He received his medical degree from the University of Toronto and completed residency training at McMaster University. Previous administrative roles include Vice President and President of the Professional Staff Association at Mackenzie Health. During his undergraduate years, he participated in a significant amount of science research leading to a primary authorship in a peer-reviewed scientific journal.